Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-19
2006-09-19
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S236000
Reexamination Certificate
active
07109199
ABSTRACT:
The present invention includes compound of formula (I),or a derivative thereof, wherein Y is CH or N; R1is unsubstituted or substituted alkyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted cycloalkenyl, unsubstituted or substituted aryl, aralkyl wherein the aryl and the alkyl moieties may each independently be unsubstituted or substituted, aralkenyl wherein the aryl, and alkenyl moieties may each independently be unsubstituted or substituted, unsubstituted or substituted heterocyclyl, or heterocyclylalkyl wherein the heterocyclyl and the alkyl moieties may each independently be unsubstituted or substituted; and R2is unsubstituted aryl or unsubstituted or substituted or substituted heteroaryl. Additionally the present invention includes a process for preparing such a compound, a pharmaceutical composition containing such a compound, and the use of such a compound in medicine.
REFERENCES:
patent: 22 38 400 (2001-08-01), None
patent: 0 063 754 (1982-11-01), None
patent: 01/57022 (2001-08-01), None
patent: 01/81345 (2001-11-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al., Advanced Drug Delivery Reviews 48: Mar. 26, 2001.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Nikoulina et al., Diabetes 49 : 263-271, 2000 .
Ferkey et al. Developmental Biology 225 : 471-479, 2000.
M. Saeda et al., “Synthesis and biological activities of some new pyridazine derivatives,”Chemical Abstracts, vol. 111, No. 13, p. 381 (1989).
A.Deeb et al., “Pyridazine derivatives and related compounds. Part 5. Pyrazolo'3,4-clpyridazine: synthesis and some reactions,”Heterocycles, vol. 32, No. 5, 1991, pp. 895-900.
M.M. Fawzy et al., “Synthesis of some new 3,4/4,6-disubstituted-1,2,4-triazine-5-one s bearing a pyrazolo-pyridazine moiety,”Chemical Abstracts, vol. 117, No. 7, Aug. 17, 1992, p. 798.
Garland Stephen
Haigh David
Hickey Deidre Mary Bernadette
Liddle John
Smith David Glynn
Balasubramanian Venkataraman
Coulter Kathryn L.
Fix Amy H.
SmithKline Beecham Corporation
LandOfFree
Pyrazolopyridines and pyrazolopyridazines as antidiabetics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolopyridines and pyrazolopyridazines as antidiabetics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolopyridines and pyrazolopyridazines as antidiabetics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3524154